GlassScriptPhysician profile
Laura Pelaez
NPI 1245471234
$2,285.34
in general payments reported to CMS, 2019-2025
13 companies · $840 in 2025
The $840 reported for 2025 was more than what 76% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.68 · 2022: $321 · 2023: $439 · 2024: $597 · 2025: $840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,876.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $317.23 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Axogen | $274.61 | 2024-2025 | Axoguard Nerve Cap, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Olympus America INC. | $272.89 | 2022-2023 | Rhino-Laryngo Videoscope |
| Stryker Corporation | $199.20 | 2023-2024 | N/A, Xpress Ent Dilation System, Clarifix Cryotherapy Device |
| Polynovo North America LLC | $195.75 | 2024-2025 | Novosorb Btm |
| Atos Medical INC | $187.82 | 2024 | Provox Life Home Hme |
| Smith+Nephew, INC. | $178.25 | 2019-2024 | Rf20000, Coblation |
| Medtronic, INC. | $160.61 | 2025 | Stealthstation S8 Platform |
| Inspire Medical Systems, INC. | $151.96 | 2023 | Inspire |
| Genzyme Corporation | $139.17 | 2024-2025 | |
| Alk-Abello, INC | $104.32 | 2022 | |
| Ambu INC. | $89.80 | 2022 | |
| Amgen INC. | $13.73 | 2025 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Pelaez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.